Related Experiment Video
Updated: Jan 25, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Childhood obesity in New Zealand
Valentina Chiavaroli1, John D Gibbins2, Wayne S Cutfield3,4,5
1Neonatal Intensive Care Unit, Pescara Public Hospital, Pescara, Italy.
Insights
Over one-third of New Zealand children and adolescents are overweight or obese, disproportionately affecting Māori, Pacific, and low-SES groups. Targeted prevention strategies are crucial for this pediatric obesity epidemic.
Area of Science:
- Public Health
- Pediatrics
- Epidemiology
Background:
- Pediatric obesity is a global health crisis with significant long-term consequences.
- Early life factors influence childhood obesity development.
- Understanding obesity prevalence and risk factors in New Zealand children is critical.
Purpose of the Study:
- To assess the extent of overweight and obesity in New Zealand's pediatric population.
- To identify key risk factors contributing to childhood obesity in New Zealand.
- To examine comorbidities associated with pediatric obesity in New Zealand.
Main Methods:
- Systematic literature searches were conducted across PubMed, Web of Science, and Google Scholar.
- Key search terms included "obesity", "overweight", "children", "adolescents", and "New Zealand".
Main Results:
- Over 33% of New Zealand children (aged 2-14) are overweight or obese.
- Māori, Pacific, and socioeconomically disadvantaged children face higher obesity rates.
- Obesity is linked to cardiometabolic, gastrointestinal, and psychological issues, particularly in at-risk groups.
Conclusions:
- New Zealand has a high prevalence of overweight and obese children, with significant ethnic and socioeconomic disparities.
- Addressing pediatric obesity is a public health priority for current and future generations.
- Future interventions must prioritize prevention from a young age, targeting high-risk populations.
Background:
Paediatric obesity has reached epidemic proportions globally, resulting in significant adverse effects on health and wellbeing. Early life events, including those that happen before, during, and after pregnancy can predispose children to later obesity. The purpose of this review is to examine the magnitude of obesity among New Zealand children and adolescents, and to determine their underlying risk factors and associated comorbidities.
Data Sources:
PubMed, Web of Science, and Google Scholar searches were performed using the key terms "obesity", "overweight", "children", "adolescents", and "New Zealand".
Results:
Obesity is a major public health concern in New Zealand, with more than 33% of children and adolescents aged 2-14 years being overweight or obese. Obesity disproportionately affects Māori (New Zealand's indigenous population) and Pacific children and adolescents, as well as those of lower socioeconomic status. New Zealand's obesity epidemic is associated with numerous health issues, including cardiometabolic, gastrointestinal, and psychological problems, which also disproportionately affect Māori and Pacific children and adolescents. Notably, a number of factors may be useful to identify those at increased risk (such as demographic and anthropometric characteristics) and inform possible interventions.
Conclusions:
The prevalence of overweight and obese children and adolescents in New Zealand is markedly high, with a greater impact on particular ethnicities and those of lower socioeconomic status. Alleviating the current burden of pediatric obesity should be a key priority for New Zealand, for the benefit of both current and subsequent generations. Future strategies should focus on obesity prevention, particularly starting at a young age and targeting those at greatest risk.
Related Concept Videos
Obesity
Erikson's Theory on Socioemotional Development during Childhood
The first four of Erikson's eight...
Drug Dosing: Obese Patients
Piaget's Theory of Cognitive Development from Childhood into Adulthood
Schemata: Building Blocks of Knowledge
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

